Clinical Trial Update: Dyslipidemia Treatment in Thailand and Cardiovascular Outcomes

View source ↗

Summary

AstraZeneca-sponsored clinical trial on dyslipidemia treatment in Thailand investigating cardiovascular outcomes has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia

Snippet

Sponsor: AstraZeneca | Conditions: Dyslipidemia | Status: WITHDRAWN